Skip to main content
Top of the Page

Dark Horse Regenerative Medicine


Dark Horse Consulting Regenerative Medicine (DHCRM), a specialized advisory practice within Dark Horse Consulting Group, brings together over 300 years of collective industry experience to help innovators navigate the full journey from concept to commercialization in regenerative medicine. Formerly known as Bruder Consulting & Ventures Group, the practice joined DHCG as a specialized Regenerative Medicine department of DHC in early 2026, adding deep domain expertise across biologics, medical devices, combination products, and biomaterials to The Group's expanding capabilities. DHCRM's subject matter expertise spans regulatory strategy, clinical development, manufacturing, supply chain, and commercial planning, with particular strength in orthopedics, wound care, and plastic and reconstructive surgery. The practice's white-glove advisory approach combines rigorous technical insight with practical execution support, enabling clients to reduce risk, make informed decisions, and advance programs with confidence. Over eleven years and more than 1,000 projects completed for over 175 companies worldwide, DHCRM has established itself as a trusted strategic partner for organizations seeking experienced guidance at every critical stage of growth.

Consulting Firm


Back to Top